Patents Assigned to Blue Earth Diagnostics Limited
-
Publication number: 20240399001Abstract: The present invention relates to a ligand-SIFA conjugate, comprising, within in a single molecule two separate moieties: (a) one or more ligands which are capable of binding to Fibroblast Activation Protein (FAP), and (b) a silicon-fluoride acceptor (SI FA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom.Type: ApplicationFiled: July 8, 2022Publication date: December 5, 2024Applicant: BLUE EARTH DIAGNOSTICS LIMITEDInventors: Sabitur RAHMAN, Romain BEJOT, Guyan LIANG, Abdul Karim HAJI, Colin BARNES
-
Publication number: 20240277875Abstract: The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a ph of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/ml ethanol; and 5-10 mg/ml sodium chloride.Type: ApplicationFiled: February 7, 2024Publication date: August 22, 2024Applicants: Blue Earth Diagnostics Limited, Siemens Medical Solutions USA, Inc.Inventors: Romain BEJOT, Michael HAKA, Atilio ANZELLOTTI
-
Patent number: 12036290Abstract: The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.Type: GrantFiled: April 9, 2021Date of Patent: July 16, 2024Assignees: Blue Earth Diagnostics Limited, Siemens Medical Solutions USA, Inc.Inventors: Romain Bejot, Michael Haka, Atilio Anzellotti
-
Patent number: 11980674Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: GrantFiled: June 17, 2021Date of Patent: May 14, 2024Assignee: Blue Earth Diagnostics LimitedInventors: Eugene Teoh, Matthew Miller, Peter Gardiner
-
Publication number: 20230218255Abstract: The present disclosure relates to methods of administering [18F]-FACBC for imaging, diagnosing, and/or monitoring of myeloma bone lesions.Type: ApplicationFiled: January 6, 2023Publication date: July 13, 2023Applicant: Blue Earth Diagnostics LimitedInventor: Eugene TEOH
-
Publication number: 20230126453Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing, and monitoring of brain lesions.Type: ApplicationFiled: October 22, 2021Publication date: April 27, 2023Applicant: Blue Earth Diagnostics LimitedInventor: Eugene TEOH
-
Publication number: 20210393808Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: ApplicationFiled: June 17, 2021Publication date: December 23, 2021Applicant: Blue Earth Diagnostics LimitedInventors: Eugene TEOH, Matthew MILLER, Peter GARDINER
-
Publication number: 20210290783Abstract: The present disclosure relates to methods of administering [18F]-FACBC, The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: ApplicationFiled: February 26, 2021Publication date: September 23, 2021Applicant: Blue Earth Diagnostics LimitedInventors: Matthew MILLER, David GAUDEN, David SCHUSTER, Stefano FANTI, Cristina NANNI, Lucia ZANONI, Frode WILLOCH, Trond Velde BOGSRUD, Tore BACH-GANSMO, Alessandra MUSTO
-
Patent number: 10967077Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: GrantFiled: June 22, 2020Date of Patent: April 6, 2021Assignee: Blue Earth Diagnostics LimitedInventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
-
Patent number: 10933147Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: GrantFiled: June 22, 2020Date of Patent: March 2, 2021Assignee: Blue Earth Diagnostics LimitedInventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Bogsrud, Tore Bach-Gansmo, Alessandra Musto
-
Publication number: 20200316227Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: ApplicationFiled: June 22, 2020Publication date: October 8, 2020Applicant: Blue Earth Diagnostics LimitedInventors: Matthew MILLER, David GAUDEN, David SCHUSTER, Stefano FANTI, Cristina NANNI, Lucia ZANONI, Frode WILLOCH, Trond BOGSRUD, Tore BACH-GANSMO, Alessandra MUSTO
-
Publication number: 20200316228Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: ApplicationFiled: June 22, 2020Publication date: October 8, 2020Applicant: Blue Earth Diagnostics LimitedInventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Bogsrud, Tore Bach-Gansmo, Alessandra Musto
-
Patent number: 10716868Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: GrantFiled: October 15, 2018Date of Patent: July 21, 2020Assignee: Blue Earth Diagnostics LimitedInventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
-
Publication number: 20190105411Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: ApplicationFiled: October 15, 2018Publication date: April 11, 2019Applicant: Blue Earth Diagnostics LimitedInventors: Matthew MILLER, David GAUDEN, David SCHUSTER, Stefano FANTI, Cristina NANNI, Lucia ZANONI, Frode WILLOCH, Trond Velde BOGSRUD, Toro BACK-GANSMO, Alessandra MUSTO
-
Patent number: 10124079Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.Type: GrantFiled: December 30, 2015Date of Patent: November 13, 2018Assignee: Blue Earth Diagnostics LimitedInventors: Matthew Miller, David Gauden, David Schuster, Stefano Fanti, Cristina Nanni, Lucia Zanoni, Frode Willoch, Trond Velde Bogsrud, Tore Bach-Gansmo, Alessandra Musto
